Follistim AQ Cartridge is designed for subcutaneous injection (under the skin) using the Follistim Pen device. It is crucial to receive thorough training from your fertility nurse or healthcare provider on how to properly prepare and self-administer the injections at home.

• Preparation: The cartridge is pre-filled with the liquid medication. You will insert the cartridge into the Follistim Pen.
  
  
• Dosing: The Follistim Pen allows you to dial the exact dose prescribed by your doctor. It’s designed for precise and accurate dosing.
  
  
• Injection Technique: You will be taught how to attach a new needle for each injection, select the dose, prepare the injection site (typically in the abdomen or thigh), and inject the medication.
  
  
• Site Rotation: Always rotate injection sites to prevent irritation or damage to the skin and underlying tissue.
  
  
• Storage and Disposal: Follow instructions for storing the cartridge (refrigerated before first use, then can be room temperature or refrigerated for a limited period after first use), and properly dispose of used needles in a sharps container.
  
  
• Timing: Doses are typically administered once daily, usually at the same time each morning, for a duration determined by your doctor based on your response.
  
  
• Administration: Subcutaneous injection via the Follistim Pen.
  
  
• Training: Mandatory training by a healthcare professional for proper use.
  
  
• Key Steps: Load cartridge, dial dose, inject into rotated sites, dispose safely.
  
  
• Storage: Store unopened cartridges refrigerated; opened cartridges have limited shelf life at room temp/refrigerated.
  
  

Follistim AQ Cartridge works by supplying exogenous (external) FSH to the body. FSH is a natural hormone critical for reproduction. In women, FSH directly stimulates the ovaries to promote the growth and maturation of ovarian follicles, each containing an egg. For women undergoing ART, the goal is to stimulate multiple follicles to develop simultaneously. For those needing ovulation induction, the aim is usually to encourage one or two dominant follicles to mature. In men, FSH is essential for the proper functioning of Sertoli cells in the testes, which are crucial support cells for sperm development. By providing this vital hormone, Follistim AQ Cartridge helps to overcome deficiencies or enhance natural processes, ultimately increasing the likelihood of successful egg development, sperm production, and conception. The liquid formulation in the cartridge ensures consistent delivery with the pen device.

• Mechanism: Provides exogenous FSH to stimulate gonadal function.
• In Women: Promotes ovarian follicle growth and egg maturation.
• In Men: Supports Sertoli cells to aid sperm production.
• Outcome: Aims to improve egg and sperm quality/quantity for fertility.

While generally well-tolerated, Follistim AQ Cartridge, like all medications, can cause side effects. It’s important to be aware of these and report any concerns to your doctor immediately.

• Common Side Effects: These are often mild and include injection site reactions (pain, redness, bruising, swelling), headache, nausea, fatigue, and pelvic discomfort or pain (due to ovarian stimulation).
  
  
• Serious Side Effects (Women):
  
  
  • Ovarian Hyperstimulation Syndrome (OHSS): The most significant risk. This can range from mild (bloating, discomfort) to severe (significant abdominal pain, rapid weight gain, fluid accumulation, shortness of breath, blood clots, kidney problems). Close monitoring during treatment is crucial to manage this risk.
  • Multiple Pregnancies: The stimulation of multiple follicles significantly increases the chance of conceiving twins, triplets, or more, which carries higher health risks for both the mother and the babies.
  • Ectopic Pregnancy: While related to underlying infertility, the incidence may be higher in ART cycles.
  • Thromboembolic Events (Blood Clots): Rare but serious, can lead to conditions like stroke, pulmonary embolism, or deep vein thrombosis.
  • Ovarian Torsion: A rare event where an ovary twists, requiring immediate medical attention.
• Common: Injection site reactions, headache, nausea, fatigue, pelvic discomfort.
  
  
• Serious (Women): OHSS, multiple pregnancies, ectopic pregnancy, blood clots, ovarian torsion.
  
  
• Action: Immediately report any severe symptoms, especially those indicating OHSS (e.g., severe abdominal pain, rapid weight gain, trouble breathing).
  
  

A thorough medical evaluation by a fertility specialist is paramount before starting Follistim AQ Cartridge treatment.

• Contraindications: Follistim AQ Cartridge should not be used in patients with:
  
  
  • Primary ovarian failure (ovaries cannot respond to FSH) or primary testicular failure.
  • Uncontrolled thyroid or adrenal gland dysfunction.
  • Undiagnosed heavy or abnormal vaginal bleeding.
  • Ovarian cysts or enlargement not due to Polycystic Ovary Syndrome (PCOS).
  • Known tumors of the ovary, breast, uterus, testicle, hypothalamus, or pituitary gland.
  • Pregnancy or breastfeeding.
  • Hypersensitivity to follitropin beta, streptomycin, or neomycin (which may be present in trace amounts from the manufacturing process).
• Monitoring: Continuous and close monitoring with transvaginal ultrasounds (to measure follicle growth) and blood tests (to measure hormone levels, especially estradiol) is essential during treatment. This monitoring helps guide dosing, minimize OHSS risk, and assess the risk of multiple pregnancies.
  
  
• Risk Discussion: Your doctor will thoroughly discuss the increased risks associated with fertility treatment, including multiple pregnancies, OHSS, and potential but unproven long-term risks such as ovarian cancer.
  
  
• Self-Administration: Ensure you are properly trained and comfortable with the injection technique. If you have vision impairment, ensure a sighted individual trained in pen use assists you.
  
  
• Absolute Contraindications: Primary gonadal failure, uncontrolled endocrine disorders, undiagnosed bleeding, certain cancers, pregnancy/breastfeeding, specific allergies.
  
  
• Essential: Close medical monitoring (ultrasound, blood tests) throughout treatment.
  
  
• Patient Education: Fully understand and discuss all risks and side effects with your doctor.
  
  

When using Follistim AQ Cartridge, it is vital to inform your fertility specialist about all medications, supplements, and herbal products you are taking. While direct interactions with the Follistim AQ Cartridge’s active ingredient (follitropin beta) are not as common as with some oral medications, it is almost always used in conjunction with other fertility drugs, and their combined effect needs careful management.

• GnRH Agonists/Antagonists: These medications (e.g., Lupron, Ganirelix) are often given concurrently with Follistim AQ Cartridge to control the timing of ovulation and prevent premature egg release during a cycle. They are part of a coordinated treatment plan.
  
  
• Hormonal Contraceptives: Any form of hormonal birth control (pills, patches, rings, etc.) will interfere with the action of Follistim AQ Cartridge by suppressing the natural hormonal cycle, and their use must be discontinued before starting treatment.
  
  
• Uncontrolled Endocrine Disorders: Unmanaged thyroid or adrenal gland disorders, or pituitary tumors, can affect the efficacy and safety of Follistim AQ Cartridge and must be addressed before treatment.
  
  
• Other Gonadotropins: If you are using other FSH or LH-containing medications, your doctor will carefully manage the dosages to avoid overstimulation.
  
  
• Key Co-medications: Often combined with GnRH agonists/antagonists for cycle control.
  
  
• Interfering Medications: Hormonal contraceptives.
  
  
• Pre-existing Conditions: Uncontrolled endocrine disorders can impact treatment.
  
  

Full Disclosure: Provide your complete medication list to your fertility specialist.

The dosage of Follistim AQ Cartridge is highly individualized and determined exclusively by your fertility specialist. It is based on a complex assessment of your specific infertility diagnosis, age, body’s response, and the type of fertility procedure you are undergoing.

• For Anovulatory Women (Ovulation Induction): A common starting daily dose for the cartridge is 50-75 International Units (IU) for at least 7 days. Doses are adjusted weekly in increments of 25 or 50 IU based on ovarian response (follicle growth and estradiol levels), with a typical maximum daily dose of 250 IU.
• For ART (Controlled Ovarian Stimulation): Initial daily doses often range from 150-225 IU, adjusted every few days based on monitoring. The maximum recommended daily dose for ART cycles is typically 450 IU (though specific protocols may vary).
• For Men (Spermatogenesis Induction): This usually follows pretreatment with hCG to normalize testosterone levels. Once normalized, Follistim AQ Cartridge is typically given at 450 IU per week, divided into two (225 IU twice weekly) or three (150 IU three times weekly) subcutaneous injections, along with the continued hCG.

Treatment typically continues for 7-14 days in a cycle until adequate follicular development is achieved, at which point an hCG injection is given to trigger final egg maturation and ovulation. Never self-adjust your Follistim AQ Cartridge dosage.

• Individualized: Dosage is precisely tailored by the fertility specialist.
• Starting Doses: Vary by indication (e.g., 50-75 IU/day for OI; 150-225 IU/day for ART).
• Adjustment: Based on ongoing monitoring (ultrasound, blood hormone levels).
• Duration: Typically 7-14 days per cycle, followed by hCG trigger.

Follistim AQ Cartridge is a prescription-only medication and is not available over-the-counter. It is typically prescribed by a reproductive endocrinologist or fertility specialist.

The strict prescription requirement is due to several critical factors:

• Potency and Specificity: It is a potent hormonal medication with specific indications in complex fertility treatments.
  
  
• Risk Profile: The potential for serious side effects, particularly Ovarian Hyperstimulation Syndrome (OHSS) and multiple pregnancies, necessitates continuous and expert medical supervision.
  
  
• Diagnostic Necessity: A comprehensive diagnostic workup for infertility is required before treatment, including hormone level assessments, ultrasound imaging, and evaluation of the male partner.
  
  
• Treatment Monitoring: The medication requires frequent monitoring with ultrasound scans and blood tests to ensure patient safety, optimize treatment outcomes, and guide dose adjustments. This level of monitoring can only be provided by a specialized medical team.
  
  
• Status: Strictly prescription-only.
  
  
• Prescriber: Reproductive endocrinologist/fertility specialist.
  
  
• Rationale: Powerful effects, significant risks, complex diagnostic requirements, and need for rigorous ongoing monitoring.
  
  
• Patient Process: Requires thorough medical evaluation and close supervision throughout the treatment cycle.

1. What is Follistim AQ Cartridge used for?

• Induction of ovulation in women with anovulation

• Controlled ovarian stimulation for assisted reproduction (e.g., IVF)

• Spermatogenesis stimulation in men with hypogonadotropic hypogonadism

2. What drug class does it belong to? Recombinant gonadotropin (FSH analog).

3. What is the active ingredient? Follitropin beta (recombinant human FSH).

4. What strengths are available? Cartridges containing 300 IU, 600 IU, or 900 IU of FSH.

5. How is it administered? Subcutaneous injection using the Follistim Pen device.

6. What is the usual starting dose?

• Women: 50 IU daily for 7 days, adjusted based on response

• Men: 150 IU three times per week, often combined with hCG

7. What are common side effects? Abdominal pain, bloating, headache, injection site reactions, nausea.

8. Can it cause serious reactions? Yes—Ovarian Hyperstimulation Syndrome (OHSS), multiple births, thromboembolism, and hypersensitivity.

9. Is it safe during pregnancy? No—contraindicated during pregnancy.

10. Is a prescription required? Yes, and it must be used under specialist supervision.

11. Is it available in Pakistan? Yes, through fertility clinics and specialty pharmacies.

12. Can it be used with other fertility drugs? Yes—often combined with hCG, GnRH agonists/antagonists, or progesterone.

13. How is it stored? Refrigerate at 2–8°C; may be stored at room temperature (≤25°C) for up to 3 months.

14. What makes it different from urinary FSH products? Follistim AQ is recombinant, offering higher purity and consistent dosing.

15. Is it used in IVF protocols? Yes—commonly used for controlled ovarian stimulation.

16. Can men use Follistim AQ Cartridge? Yes—for treating male infertility due to FSH deficiency.

17. What should be monitored during use? Estradiol levels, follicle growth via ultrasound, and signs of OHSS.

18. Is self-injection possible? Yes—with proper training using the Follistim Pen.

19. What are contraindications?

• Primary ovarian failure

• Uncontrolled thyroid/adrenal disorders

• Tumors of reproductive organs

• Pregnancy

20. What excipients are included? Sodium phosphate, polysorbate 20, benzyl alcohol (preservative), and water for injection.